PubMed Health treatment related to Premenstrual Tension: 63
There isn’t much good research on what can help reduce PMS. So it isn’t clear how effective many of the PMS treatments are. Girls and women with PMS often try out different things to reduce their symptoms. For instance, some women with mild PMS try out relaxation techniques, acupuncture , getting more exercise , drinking less alcohol and coffee, or eating less salt. Others use herbal products and dietary supplements such as chaste tree extracts (Vitex agnus castus), St. John’s wort, calcium or pyridoxine vitamin B6 ). More severe PMS can be treated with a number of medications. But many of these medications haven’t been approved for the treatment of PMS, and they can have side effects: Hormone medications like the birth control pill or hormone patches affect women’s hormone levels and lead to an improvement in PMS or PMDD. Antidepressants : SSRIs (selective serotonin reuptake inhibitors ) can help reduce severe psychological problems caused by PMS or PMDD. Painkillers can effectively relieve severe period pain and are usually well tolerated. There is very little research on whether they also help in PMS, though. Women who have problems with PMS-related water retention can take diuretics (water pills ) . If PMS causes psychological problems, cognitive behavioral therapy (CBT) is an option. But it isn’t clear whether it helps in PMS.
Drugs for Premenstrual Tension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 111)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Naproxen |
Approved, Vet_approved |
Phase 4 |
|
22204-53-1 |
156391 1302 |
Synonyms:
(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetate
(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(+)-(S)-6-Methoxy-a-methyl-2-naphthaleneacetate
(+)-(S)-6-Methoxy-a-methyl-2-naphthaleneacetic acid
(+)-(S)-6-Methoxy-α-methyl-2-naphthaleneacetate
(+)-(S)-6-Methoxy-α-methyl-2-naphthaleneacetic acid
(+)-(S)-Naproxen
(+)-2-(6-Methoxy-2-naphthyl)propionate
(+)-2-(6-Methoxy-2-naphthyl)propionic acid
(+)-2-(Methoxy-2-naphthyl)-propionate
(+)-2-(Methoxy-2-naphthyl)-propionic acid
(+)-2-(Methoxy-2-naphthyl)-propionsaeure
(+)-2-(METHOXY-2-NAPHTHYL)-PROPIONSÄURE
(+)-Naproxen
(<i>S</i>)-naproxen|Aleve®|Naprosy®
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionate
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-(+)-Naproxen
(S)-2-(6-Methoxy-2-naphthyl)propanoate
(S)-2-(6-Methoxy-2-naphthyl)propanoic acid
(S)-2-(6-Methoxy-2-naphthyl)propionate
(S)-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetate
(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-6-Methoxy-a-methyl-2-naphthaleneacetate
(S)-6-Methoxy-a-methyl-2-naphthaleneacetic acid
(S)-6-Methoxy-α-methyl-2-naphthaleneacetate
(S)-6-Methoxy-α-methyl-2-naphthaleneacetic acid
(S)-Naproxen
2-(6-Methoxy-2-naphthyl)propionic acid
2-(6-Methoxynaphthalen-2-yl)propanoate
Acusprain
Aleve
Anaprox
Anexopen
Apronax
Artagen
Arthrisil
ARTHROSIN 250
ARTHROSIN 250 EC
ARTHROSIN 500
ARTHROSIN 500 EC
Artrixen
Artroxen
Atiflan
Axer
Bipronyl
Bonyl
Calosen
Clinosyn
CONDROTEC
Congex
Danaprox
Daprox
Diocodal
DL Naproxen
DL-Naproxen
D-Naproxen
Duk
Dysmenalgit
Dysmenalgit N
Ec-naprosyn
Equiproxen
FEMINAX ULTRA
Flexipen
Floginax
|
Fuxen
Genoxen
GRENOXAL
KENOSYN
LARAFLEX
Laser
Lefaine
Leniartil
Methoxypropiocin
MNPA
Nafasol
Naixan
Nalyxan
Napflam
Napmel
Naposin
NAPRATEC OP
NAPRELAN
Napren
Naprium
Naprius
NAPROLAG
Naprosin
Naprosine
NAPROSY
Naprosyn
NAPROSYN 375
NAPROSYN EC
Naprosyne
NAPROXEN
Naproxen sodium
Naproxenate, sodium
Naproxene
NAPROXÈNE
Naproxeno
Naproxenum
Naprux
Naxen
Naxyn
Niaxan
Novonaprox
Nycopren
Opipramol
Panoxen
Pranoxen
PRANOXEN CONTINUS
Prexan
PROSAID
Proxen
Proxine
Reuxen
RHEUFLEX 250
RHEUFLEX 500
RIMOXYN
RS-3540
Sodium naproxenate
Sodium, naproxen
STIRLESCENT
Synflex
TIMPRON
TIMPRON 250 EC
TIMPRON 500 EC
VALROX
Veradol
VIMOVO
Xenar
|
|
2 |
|
Fluoxetine |
Approved, Vet_approved |
Phase 4 |
|
54910-89-3 |
3386 |
Synonyms:
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine
(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
Adofen
Animex-On
Deprex
Eufor
Fluctin
Fluoxeren
Fluoxetin
Fluoxetina
Fluoxetina [INN-Spanish]
Fluoxetina [Spanish]
FLUOXETINE
Fluoxétine
Fluoxetine Hcl
Fluoxetine hydrochloride
|
Fluoxetinum
Fluoxetinum [INN-Latin]
Fluval
Fontex
Foxetin
N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
NSC-283480
Portal
Prozac
Prozac Weekly
Prozac®
Pulvules
Reneuron
Sarafem
Symbyax
|
|
3 |
|
Ethinylestradiol |
Approved |
Phase 4 |
|
57-63-6 |
5991 |
Synonyms:
(1S,10R,11S,14R,15S)-14-ETHYNYL-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
17 ALPHA-ETHINYLESTRADIOL
17 ALPHA-ETHYNYLESTRADIOL
17 ALPHA-ETHYNYLOESTRADIOL
17α-ethynylestradiol|ethinyl estradiol
17a-Ethinyl estradiol
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol-L7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17Α-ethinyl estradiol
17Α-ETHYNYLESTRADIOL
Alora
Amenoron
Anovlar
Chee-O-gen
Chee-O-genf
Diognat-e
Diogyn e
Diogyn-e
Dyloform
Effik brand OF ethinyl estradiol
ENOVID
ENOVID-E
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Eston-e
Estoral
Estoral {[orion]}
Estorals
Estradiol, ethinyl
Estradiol, ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl estradiol
Ethinyl estradiol hemihydrate
Ethinyl estradiol, (8 alpha)-isomer
Ethinyl estradiol, (8 alpha,17 alpha)-isomer
Ethinyl estradiol, (8 alpha,9 beta,13 alpha,14 beta)-isomer
Ethinyl estradiol, (9 beta,17 alpha)-isomer
Ethinyl oestradiol effik
Ethinylestradiol
Ethinylestradiol jenapharm
ETHINYLESTRADIOLUM
Ethinylestriol
Ethinyloestradiol
|
Ethinyl-oestradiol effik
ETHINYL-OESTRANOL
Ethynyl estradiol
Ethynylestradiol
ETHYNYLOESTRADIOL
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
ETINILESTRADIOL
Etinoestryl
Etistradiol
Etivex
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
Hemihydrate, ethinyl estradiol
Inestra
Innofem
Jenapharm brand OF ethinyl estradiol
Jenapharm, ethinylestradiol
Kolpolyn
Linoral
Lynoral
Menolyn
Menostar
Microfollin
Microfollin forte
Neo-estrone
Nogest-S
NORINYL
Novestrol
NSC-10973
Oradiol
Orestralyn
Orestrayln
Organon brand OF ethinyl estradiol
Ovex
OVULEN
OVULEN-21
OVULEN-28
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn m
Progynon C
Progynon m
Schering brand OF ethinyl estradiol
Schering-plough brand OF ethinyl estradiol
Spanestrin
Thiuram e
Thiuranide
Vagifem
Ylestrol
|
|
4 |
|
Drospirenone |
Approved |
Phase 4 |
|
67392-87-4 |
68873 |
Synonyms:
1,2-Dihydrospirorenone
1,2-Dihydro-spirorenone
15b,16b-dimethylene-3-oxo-17a-pregn-4-ene-21,17-carbolactone
15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone
6b,7Beta
6beta,7Beta
6beta,7beta,15beta,16beta-Dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolacton
6BETA,7BETA;15BETA,16BETA-DIMETHYLENE-3-OXO-17ALPHA-PREGN-4-ENE-21,17-CARBOLACTONE
6Β,7beta
6β,7β
6Β,7β,15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17 carbolactone
ANGELIQ
|
Dehydrospirorenone
Dihydrospirorenone
dihydrospirorenone|Slynd®|Yasmin®|ZK30595
Drospirenona
DROSPIRENONE
Drospirénone
Drospirenonum
DRSP
Slynd
YASMIN
ZK30595
ZK-30595
|
|
5 |
|
Estradiol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
50-28-2 |
5757 |
Synonyms:
(+)-3,17B-ESTRADIOL
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17BETA)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(17Β)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(1S,10R,11S,14S,15S)-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
(8R,9S,13S,14S,17S)-13-METHYL-6,7,8,9,11,12,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHRENE-3,17-DIOL
[<sup>3</sup>H]-estradiol|[<sup>3</sup>H]-estrogen|[<sup>3</sup>H]E2|[<sup>3</sup>H]estradiol
13B-METHYL-1,3,5(10)-GONATRIENE-3,17B-OL
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17B-ESTRADIOL
17BETA OESTRADIOL
17BETA-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17BETA-ESTRADIOL
17BETA-OESTRADIOL
17B-OESTRADIOL
17Β oestradiol
17Β-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17β-estradiol
17Β-OESTRADIOL
3,17B-DIHYDROXYESTRA-1,3,5(10)-TRIENE
3,17B-ESTRADIOL
3,17-EPIDIHYDROXYESTRATRIENE
ADGYN ESTRO
AERODIOL
AGOFOLLIN
ALFATRADIOL
ALORA
ALTRAD
AMNESTROGEN
AQUADIOL
AQUAGEN
BARDIOL
BEDOL
B-ESTRADIOL
BETA-ESTRADIOL
CIS-ESTRADIOL
CLIMADERM
CLIMARA
CLIMARA PRO
COMPUDOSE
CORPAGEN
Delestrogen
DELTA-ESTRADIOL
DELTA-OESTRADIOL
DEPO-ESTRADIOL
DERMESTRIL
DERMESTRIL 100
DERMESTRIL 25
DERMESTRIL 50
DERMESTRIL SEPTEM 25
DERMESTRIL SEPTEM 50
DERMESTRIL SEPTEM 75
DESTRADIOL
D-ESTRADIOL
DIHYDROFOLLICULAR HORMONE
DIHYDROFOLLICULIN
DIHYDROMENFORMON
DIHYDROTHEELIN
DIHYDRO-THEELIN
DIHYDROXYESTRIN
DIMENFORMON
DIOGYN
DIOGYNETS
DIVIGEL
D-OESTRADIOL
E2
E2|estrogen|oestrodiol|oestrogen
E-CYPIONATE
ELESTRIM
ELESTRIN
ELLESTE SOLO
ELLESTE SOLO MX 40
ELLESTE SOLO MX 80
ENCORE
EPIESTRIOL 50
ESCLIM
ESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
ESTRACE
ESTRADERM
ESTRADERM MX 100
ESTRADERM MX 25
ESTRADERM MX 50
ESTRADERM MX 75
ESTRADERM TTS
ESTRADERM TTS 100
ESTRADERM TTS 25
ESTRADERM TTS 50
ESTRADIOL
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
ESTRADIOL HEMIHYDRATE
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol valerate
Estradiol valeriante
|
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17b
ESTRADIOL-17BETA
ESTRADIOL-17-BETA
Estradiol-17β
ESTRADIOLUM
ESTRADOT
ESTRALDINE
ESTRASORB
ESTRING
ESTRING VAGINAL RING
ESTROCLIM
ESTROCLIM 50
ESTROGEL
ESTROGEL HBF
ESTROGEN
ESTROVITE
EVAMIST
EVOREL
EVOREL 100
EVOREL 25
EVOREL 50
EVOREL 75
FEMATRIX 40
FEMATRIX 80
FEMESTRAL
FEMOGEN
FEMPATCH
FEMSEVEN 100
FEMSEVEN 50
FEMSEVEN 75
FOLLICYCLIN
GELESTRA
GINOSEDOL
GVNODIOL
GYNERGON
GYNODIOL
GYNOESTRYL
GYNOGEN
IMVEXXY
INNOFEM
LAMDIOL
MACRODIOL
MENOREST
MENOREST 37.5
MENOREST 50
MENOREST 75
MENORING 50
MENOSTAR
MINIVELLE
NORDICOL
Novartis pharmaceuticals brand OF estradiol
NSC-20293
NSC-9895
OESCLIM
OESTERGON
OESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
OESTRADIOL
OESTRODIOL
OESTROGEL
OESTROGEN
OESTROGLANDOL
Orion brand OF estradiol
OVAHORMON
OVASTEROL
OVASTEVOL
OVOCYCLIN
OVOCYLIN
PERLATANOL
PRIMOFOL
PROFOLIOL
PROFOLIOL B
PROGYNON
Progynon depot
PROGYNON DH
Progynon-depot
Progynova
PROGYNOVA TS
SANDRENA
SANDRENA 1
SYNDIOL
SYSTEN
VAGIFEM
VAGIFEM 18
VAGIFEM 8
VIVELLE
VIVELLE-DOT
WC3011
WC-3011
ZUMENON
Β-estradiol
|
|
6 |
|
Polyestradiol phosphate |
Approved |
Phase 4 |
|
28014-46-2 |
|
Synonyms:
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol polymer with phosphoric acid
ESTRADIOL PHOSPHATE
Estradiol phosphate polymer
ESTRADURIN
Fosfato de poliestradiol
LEO-114
Oestradiol phosphate polymer
|
Phosphate de polyestradiol
Poly(estradiol phosphate)
POLYEST PHOS
POLYESTRADIOL PHOS PHOSPHATE
POLYESTRADIOL PHOSPHATE
Polyestradioli phosphas
|
|
7 |
|
Sertraline |
Approved |
Phase 4 |
|
79617-96-2 |
68617 |
Synonyms:
(+)-Sertraline
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
Altruline
Apo sertraline
Apo-sertraline
Apotex brand OF sertraline hydrochloride
Aremis
Besitran
Boehringer ingelheim brand OF sertraline hydrochloride
cis-(+)-Sertraline
CP 51974
CP-519741
CP-51974-1
CP-51974-1|CP-519741|Lustral®|Zoloft®
Esteve brand OF sertraline hydrochloride
Gen sertraline
Genpharm brand OF sertraline hydrochloride
Gen-sertraline
Gladem
Hydrochloride, sertraline
Lacer brand OF sertraline hydrochloride
Lustral
|
Novo sertraline
Novopharm brand OF sertraline hydrochloride
Novo-sertraline
Parke davis brand OF sertraline hydrochloride
Pfizer brand OF sertraline hydrochloride
Ratio sertraline
Ratiopharm brand OF sertraline hydrochloride
Ratio-sertraline
Rhoxal sertraline
Rhoxalpharma brand OF sertraline hydrochloride
Rhoxal-sertraline
Roerig brand OF sertraline hydrochloride
Sealdin
Sertralina
Sertralina [Spanish]
SERTRALINE
Sertraline hydrochloride
Sertraline hydrochloride (1S-cis)-isomer
Sertralinum
Sertralinum [Latin]
Sultamicillin Tosylate
Zoloft
|
|
8 |
|
Hydrocortisone succinate |
Approved |
Phase 4 |
|
2203-97-6 |
3643 |
Synonyms:
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
Cortisol 21-(hydrogen succinate)
Cortisol succinate
HYDROCORTISONE HEMISUCCINATE
|
Hydrocortisone hemisuccinate anhydrous
Hydrocortisone hydrogen succinate
HYDROCORTISONE SUCCINATE
Hydroxycortisone succinate
NSC-7576
|
|
9 |
|
Hydrocortisone acetate |
Approved, Vet_approved |
Phase 4 |
|
50-03-3 |
|
Synonyms:
21-O-acetylcortisol
BARQUINOL HC
CHLOROMYCETIN HYDROCORT
COLIFOAM
CORTEF ACETATE
CORTIFOAM
Cortisol 21-acetate
CORTRIL
CORTUCID
DRICORT
EPIFOAM
FRAMYCORT
FUCIDIN H
GENTICIN HC
GENTISONE HC
|
GPPE EAR SUSP
GPPE EYE CRM
GPPE FOAM AERO
HC45 HYDROCORT
HEMSOL-HC
HEPACORT PLUS
HYDROCAL
HYDROCORTISONE 21-ACETATE
HYDROCORTISONE ACETATE
HYDROCORTONE
LANACORT
MICORT-HC
NEO-CORTEF
NSC-741
ORABASE HCA
|
|
10 |
|
Hydrocortisone |
Approved, Vet_approved |
Phase 4 |
|
50-23-7 |
3640 5754 |
Synonyms:
(11ALPHA,14BETA)-11,17,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE
(11b)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11Β)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(1S,2R,10S,11S,14S,15S,17S)-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
11 Epicortisol
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b,17a,21-Trihydroxy-4-pregnene-3,20-dione
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11-beta-Hydrocortisone
11beta-Hydroxycortisone
11-beta-Hydroxycortisone
11b-Hydrocortisone
11b-Hydroxycortisone
11-Epicortisol
11-Hydrocortisone
11Β,17α,21-trihydroxy-4-pregnene-3,20-dione
11Β-hydrocortisone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
17-Hydroxycorticosterone
4-Pregnen-11b,17a,21-triol-3,20-dione
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnen-11β,17α,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
ACETASOL HC
ACTICO МИХАИЛRT
Acticort
Acticort®|Efmody®|Plenadren®
Aeroseb HC
Aeroseb-HC
Alacort
Ala-cort
Ala-scalp
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort-HC
ANUGESIC HC
Anusol HC
ANUSOL PLUS HC
ANUSOL SOOTHING RELIEF
Anusol-HC
Aquacort
Aquanil HC
Balneol-HC
Barseb HC
Basan-corti
Beta-HC
b-HC
CaldeCORT spray
CALMURID HC
CANESTEN HC
Cetacort
Chronocort
CIPRO HC
Clear aid
Cleiton
Cobadex
Colocort
Compound F
CORLAN
Cor-oticin
Cortanal
Cor-tar-quin
Cort-dome
Cortef
CORTENEM
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisolonum
Cortisporin
Cortisporin otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cort-quin
CORTRIL
Cremesone
Cremicort-H
Cutisol
DAKTACORT
DAKTACORT HYDROCORT
Delacort
DERMA CARE HYDROCORT
Dermacort
Derm-aid
DERMASPRAY DEMANG
Dermil
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
ECONACORT
Ef corlin
Efcorbin
Efcortelan
EFCORTELAN P
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
EURAX-HC
EURAX-HYDROCORT
Evacort
EXE-CORT
Ficortril
Fiocortril
Flexicort
Foille insetti
Genacort
GERMOLOIDS HC
Glycort
GREGODERM
gyno-Cortisone
HC
|
HC #1
HC #4
HC (HYDROCORTISONE)
HC45
H-Cort
Heb cort
Heb-cort
Hi-cor
Hidalone
hidro-Colisona
Hidrocortisona
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
hydro-Adreson
hydro-Colisona
Hydrocort
HYDROCORT IN CALAMINE OILY
HYDROCORT IN CETOMACROGOL FOR A
HYDROCORT IN WTE SOFT PARAF
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone acetate
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone butyrate
Hydrocortisone free alcohol
Hydrocortisone in absorbase
Hydrocortisone sodium phosphate
Hydrocortisone valerate
Hydrocortisone, (11 alpha)-isomer
Hydrocortisone, (9 beta,10 alpha,11 alpha)-isomer
Hydrocortisonum
Hydrocortistab
Hydrocortisyl
HYDROCORTONE
HYDRODERM
HYDRODERM HC
hydro-RX
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone lotion
Idrocortisone
Incortin-H
Incortin-hydrogen
JUNGLE FOR
Kendall's compound F
Komed HC
Kyypakkaus
Lacticare HC
Lacticare-HC
Lactisona
Locoid
Lubricort
Maintasone
Medicort
Meusicort
Micort-HC
Mildison
MILDISON LIPOCREAM
Milliderm
neo-Cort-dome
neo-Cortef
Neosporin-H ear
Nogenic HC
NSC-10483
Nutracort
NYBADEX
Nystaform-HC
Ophthocort
Optef
Otalgine
Otic-neo-cort-dome
Otobiotic
Otocort
OTOSEPTIL
Otosone-F
OTOSPORIN
Pediotic suspension
Penecort
PERINAL
Permicort
Plenadren
Polcort H
Preparation H hydrocortisone cream
Prepcort
Prestwick_265
Prevex HC
Proctocort
PROCTOCREAM HC
Proctofoam
PROCTOFOAM HC
PROCTOSEDYL
Protocort
QUINOCORT
Racet
Rectoid
Reichstein's substance m
Remederm HC
Sanatison
Scalpicin capilar
Schericur
Scheroson F
SENTIAL HC
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral hydrocort
Tarcortin
Terra-cortril
TERRA-CORTRIL NYSTATIN
Texacort
Timocort
TIMODINE
Topicort
TOPISONE
Transderma H
Traumaide
TRI-CICATRIN
U-cort
Uniderm
UNIROID
UNIROID HC
Vioform-hydrocortisone
VoSol HC
Vytone
XYLOPROCT
Zenoxone
β-HC
|
|
11 |
|
Paroxetine |
Approved, Investigational |
Phase 4 |
|
61869-08-7 |
43815 |
Synonyms:
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(−)-(3S,4R)-4-(P-FLUOROPHENYL)-3-((3,4-(METHYLENEDIOXY)PHENOXY)METHYL)PIPERIDINE
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
Acetate, paroxetine
Anhydrous, paroxetine hydrochloride
Aropax
BRL-29060
Hemihydrate paroxetine hydrochloride
Hemihydrate, paroxetine hydrochloride
Hydrochloride anhydrous, paroxetine
Hydrochloride hemihydrate, paroxetine
Hydrochloride, hemihydrate paroxetine
Hydrochloride, paroxetine
Maleate, paroxetine
Paroxetina
Paroxetina [INN-Spanish]
PAROXETINE
Paroxetine acetate
|
Paroxetine Hcl
Paroxetine hydrochloride
paroxetine hydrochloride (anhydrous or hemihydrate)|Paxil®|Seroxat®
Paroxetine hydrochloride anhydrous
Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride, hemihydrate
Paroxetine maleate
Paroxetine, cis-(-)-isomer
Paroxetine, cis-(+)-isomer
Paroxetine, trans-(+)-isomer
Paroxetinum
Paroxetinum [INN-Latin]
Paxil
PAXIL [AS HYDROCHLORIDE]
Paxil CR
PEXEVA
Seroxat
Seroxat CR
|
|
12 |
|
Flutamide |
Approved, Investigational |
Phase 4 |
|
13311-84-7 |
3397 |
Synonyms:
1a Brand OF flutamide
4'-Nitro-3'-trifluoromethylisobutyranilide
a,a,a-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide
alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide
Alphapharm brand OF flutamide
Apimid
Apo flutamide
Apo-flutamide
ApoFlutamide
Apogepha brand OF flutamide
Apotex brand OF flutamide
Azupharma brand OF flutamide
Cebatrol
Cell pharm brand OF flutamide
Chephasaar brand OF flutamide
Chimax
Chiron brand OF flutamide
Ciclum brand OF flutamide
Cytamid
Drogenil
Esparma brand OF flutamide
Essex brand OF flutamide
Euflex
Eulexin
Eulexin®|SCH-13521
Eulexine
Fluken
Flulem
Flumid
Fluta 1a pharma
Fluta cell
Fluta gry
Flutacell
Fluta-cell
Fluta-gry
FlutaGRY
Flutamid
Flutamida
Flutamide
Flutamide usp25
Flutamidum
|
Flutamin
Flutandrona
Flutaplex
Flutexin
FTA
Fugerel
Grisetin
Gry brand OF flutamide
Hexal brand OF flutamide
Inibsa brand OF flutamide
Ipsen brand OF flutamide
Juta brand OF flutamide
Kendrick brand OF flutamide
Lemery brand OF flutamide
NFBA
Niftholide
Niftolid
Niftolide
Novo flutamide
Novo-flutamide
NovoFlutamide
Novopharm brand OF flutamide
NSC-215876
Oncosal
Pharmascience brand OF flutamide
PMS Flutamide
PMS-Flutamide
Prasfarma brand OF flutamide
Prostacur
Prostica
Prostogenat
Q Pharm brand OF flutamide
Q-Pharm brand OF flutamide
SCH-13521
Schering brand OF flutamide
Schering plough brand OF flutamide
Schering-plough brand OF flutamide
TAD brand OF flutamide
Tedec meiji brand OF flutamide
Testotard
Α,α,α-trifluoro-2-methyl-4'-nitro-m-propionotoluidide
|
|
13 |
|
Desogestrel |
Approved |
Phase 4 |
|
54024-22-5 |
40973 |
Synonyms:
13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol
13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol
13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol
13-Ethyl-11-methylene-18,19-dinor-17a-pregn-4-en-20-yn-17-ol
13-Ethyl-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-17-ol
AIZEA
alpha-Pregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-18,19-dinor-17
Cerazette
CERELLE
Desogestrel
|
Désogestrel
Desogestrelum
DESOMONO
FEANOLLA
Marvelon
NACREZ
ORG-2969
Organon brand OF desogestrel
ZELLETA
|
|
14 |
|
Dinoprostone |
Approved |
Phase 4 |
|
363-24-6, 7448-03-5 |
5280360 |
Synonyms:
(-)-Prostaglandin e2
(15S)-prostaglandin E2
(3b,4a,5a)-4-Methylcholesta-8,24-dien-3-ol
(3beta,4alpha,5alpha)-4-Methylcholesta-8,24-dien-3-ol
(3β,4α,5α)-4-Methylcholesta-8,24-dien-3-ol
(4S,5S)-4,10,13-Trimethyl-17-(6-methylhept-5-en-2-yl)-2,3,4,5,6,7,11,12,14, 15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
(5Z)-7-[(1R,2R,3R)-3-HYDROXY-2-[(1E,3S)-3-HYDROXYOCT-1-EN-1-YL]-5-OXOCYCLOPENTYL]HEPT-5-ENOIC ACID
(5Z,11a,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-Oate
(5Z,11a,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-Oic acid
(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-Oate
(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-Oic acid
(5Z,11Α,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-Oate
(5Z,11α,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(5Z,13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoate
(5Z,13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoic acid
(5Z,13E)-(15S)-11a,15-Dihydroxy-9-oxoprosta-5,13-dienoate
(5Z,13E)-(15S)-11a,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
(5Z,13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoate
(5Z,13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoic acid
(5Z,13E)-(15S)-11Α,15-dihydroxy-9-oxoprosta-5,13-dienoate
(5Z,13E)-(15S)-11Α,15-dihydroxy-9-oxoprosta-5,13-dienoic acid
(5Z,13E,15S)-11-alpha,15-Dihydroxy-9-oxoprost-5,13-dienoate
(5Z,13E,15S)-11-alpha,15-Dihydroxy-9-oxoprost-5,13-dienoic acid
(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoate
(E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoate
(Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
[<sup>3</sup>H]-PGE2|[<sup>3</sup>H]prostaglandin E2|[<sup>3</sup>H]prostin E2
4alpha-Methyl-5alpha-cholesta-8(9),24-dien-3beta-ol
4alpha-Methyl-5alpha-cholesta-8,24-dien-3beta-ol
4alpha-Methyl-delta8,24-cholestenol
4alpha-Methylzymosterol
4a-Methyl-5a-cholesta-8,24-dien-3b-ol
4α-Methyl-5α-cholesta-8(9),24-dien-3β-ol
4α-Methyl-5α-cholesta-8,24-dien-3β-ol
|
4α-Methylzymosterol
4α-Methyl-Δ8,24-cholestenol
5-trans-PGE2
alpha, PGE2
alpha, Prostaglandin e2
Cervidil
Cervidil®|minprositin E2|minprostin E2|Propess®|prostaglandin E2
Dinoproston
Dinoprostona
Dinoprostone
DINOPROSTONE BETA-CYCLODEXTRIN CLATHRATE
Dinoprostone Prostaglandin E2
Dinoprostonum
e2 alpha, Prostaglandin
e2, Prostaglandin
e2alpha, Prostaglandin
Gel, prepidil
Glandin
L-Prostaglandin e2
Minprositin e2
Minprostin e2
NSC-165560
NSC-196514
PGE2
PGE2 alpha
PGE2alpha
Prepidil
Prepidil gel
Propess
Prostaglandin e
Prostaglandin E2
Prostaglandin e2 alpha
Prostaglandin e2alpha
Prostarmon e
Prostenon
Prostin
Prostin e2
U-12062
|
|
15 |
|
Epoprostenol |
Approved |
Phase 4 |
|
61849-14-7, 35121-78-9 |
5282411 |
Synonyms:
(5Z,13E)-(15S)-6,9a-Epoxy-11a,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9a-Epoxy-11a,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9-alpha-Epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9-alpha-Epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9Α-epoxy-11α,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9Α-epoxy-11α,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E,15S)-6,9a-Epoxy-11a,15-dihydroxyprosta-5,13-dienoate
(5Z,13E,15S)-6,9a-Epoxy-11a,15-dihydroxyprosta-5,13-dienoic acid
(5Z,9a,11a,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-Oate
(5Z,9a,11a,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-Oic acid
(5Z,9alpha,11alpha,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-Oate
(5Z,9alpha,11alpha,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-Oic acid
(5Z,9Α,11α,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-Oate
(5Z,9Α,11α,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-Oic acid
ACT-385781A
Epoprostanol
|
Epoprostenol
EPOPROSTENOL SODIUM
Epoprostenol sodium salt, (5Z,9alpha,11alpha,13E,15S)-isomer
EPOPROSTENOLSODIUM
FLOLAN
PGI2
PG-I2
PGX
Prostacyclin
PROSTACYCLIN SODIUM SALT
prostacyclin|prostacyclin I2|prostaglandin I2|vasocyclin
Prostacycline
Prostaglandin I(2)
PROSTAGLANDIN I2
Prostaglandin X
U-53217
U-53217A
Vasocyclin
VELETRI
|
|
16 |
|
Sumatriptan |
Approved, Investigational |
Phase 4 |
|
103628-46-2 |
5358 |
Synonyms:
(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide
(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulphonamide
1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide
1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulphonamide
3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide
3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulphonamide
3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide
3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulphonamide
estradiol
Glaxo wellcome brand OF sumatriptan
GR-43175C
GR-43175C|Imigran®|Tosymra® (nasal spray)
GSK Brand OF sumatriptan
Imigran
Imigran recovery
|
Imitrex
Imitrex Oral
N02CC01
NP101
Succinate, sumatriptan
Sumatran
SUMATRIPTAN
SUMATRIPTÁN
Sumatriptan GSK brand
Sumatriptan succinate
Sumatriptanum
Sumatriptanum [INN-Latin]
Sumax
TOSYMRA
TRIPTAN
|
|
17 |
|
Salmon calcitonin |
Approved, Investigational |
Phase 4 |
|
47931-85-1 |
155817456 |
Synonyms:
CALCITONIN (SALMON SYNTHETIC)
Calcitonin salmon
CALCITONIN SALMON RECOMBINANT
Calcitonin, salmon
Calcitonina salmón sintética
|
Calcitonin-salmon
CT (salmon)|Miacalcin®
FORTICAL
Recombinant salmon calcitonin
Salmon calcitonin
|
|
18 |
|
Citalopram |
Approved |
Phase 4 |
|
59729-32-7, 59729-33-8 |
2771 |
Synonyms:
[<sup>3</sup>H]-citalopram
Akarin
Bonitrile
Celapram
Celexa
Celexa®|Cipramil®|LU-10171B
Celius
Ciazil
Cilift
Cipram
CIPRAMIL
Ciprapine
Citabax
Citadur
Citalec
Citalopram
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
Citol
Citopam
Citox
|
Citrol
Cytalopram
Dalsan
Elopram
Escitalopram
Escitalopram oxalate
Humorup
Lexapro
LU 10-171-B
LU-10-171-B
Nitalapram
Oropram
PAXORAN
Pramcit
Recital
Seropram
Talam
Talohexal
Temperax
Vodelax
Zentius
Zetalo
|
|
19 |
|
Calcitonin gene-related peptide |
Investigational |
Phase 4 |
|
83652-28-2 |
91976570 |
Synonyms:
2-{[2-({6-amino-2-[(2-{[2-({2-[(2-{[2-({[1-(2-{[2-({2-[(2-{[6-amino-2-({2-[(2-{[2-({2-[(2-{[2-({2-[(2-{[2-({2-[(2-{[2-({2-[(2-{[2-({2-[({19-[(2-amino-1-hydroxypropylidene)amino]-16-(carboxymethyl)-6,9,12,15,18-pentahydroxy-7,13-bis(1-hydroxyethyl)-10-methyl-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaen-4-yl}(hydroxy)methylidene)amino]-1-hydroxy-3-methylbutylidene}amino)-1,3-dihydroxybutylidene]amino}-1-hydroxy-3-(1H-imidazol-5-yl)propylidene)amino]-5-carbamimidamido-1-hydroxypentylidene}amino)-1-hydroxy-4-methylpentylidene]amino}-1-hydroxypropylidene)amino]-1-hydroxyethylidene}amino)-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-1,3-dihydroxypropylidene}amino)-5-carbamimidamido-1-hydroxypentylidene]amino}-1,3-dihydroxypropylidene)amino]-1-hydroxyethylidene}amino)-1-hydroxyethylidene]amino}-1-hydroxy-3-methylbutylidene)amino]-1-hydroxy-3-methylbutylidene}amino)-1-hydroxyhexylidene]amino}-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene)amino]-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene}amino)-1-hydroxy-3-phenylpropylidene]amino}-3-methylbutanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-1,3-dihydroxybutylidene]amino}-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene)amino]-1-hydroxy-3-methylbutylidene}amino)-1-hydroxyethylidene]amino}-1,3-dihydroxypropylidene)amino]-1-hydroxyhexylidene}amino)-1-hydroxypropylidene]amino}-3-phenylpropanoate
Calcitonin gene related peptide
Calcitonin-gene-related peptide
|
|
|
20 |
|
Tezosentan |
Investigational |
Phase 4 |
|
180384-57-0 |
|
Synonyms:
5-Isopropyl-pyridine-2-sulfonic acid 6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(2-1H-tetrazol-5-yl--pyridin-4-yl)--pyrimidin-4-ylamide
ACT-050089
RO-610612
|
RO-61-0612
TEZOSENTAN
Veletri
|
|
21 |
|
Dexetimide |
Withdrawn |
Phase 4 |
|
21888-98-2 |
30843 |
Synonyms:
(+)-BENZETIMIDE
(+)-benzetimide|R 16470|Tremblex®
Dexetimida
DEXETIMIDE
|
Dexetimidum
R 16470
R-16470 [AS HYDROCHLORIDE]
TREMBLEX
|
|
22 |
|
Analgesics |
|
Phase 4 |
|
|
|
23 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
24 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
25 |
|
Contraceptives, Oral |
|
Phase 4 |
|
|
|
26 |
|
Contraceptive Agents |
|
Phase 4 |
|
|
|
27 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
28 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
29 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
30 |
|
Drospirenone and ethinyl estradiol combination |
|
Phase 4 |
|
|
|
31 |
|
Contraceptives, Oral, Combined |
|
Phase 4 |
|
|
|
32 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 4 |
|
|
|
33 |
|
Estrogens |
|
Phase 4 |
|
|
|
34 |
|
Estradiol 3-benzoate |
|
Phase 4 |
|
|
|
35 |
|
Estradiol 17 beta-cypionate |
|
Phase 4 |
|
|
|
36 |
|
Hormones |
|
Phase 4 |
|
|
|
37 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
38 |
|
Progestins |
|
Phase 4 |
|
|
|
39 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4 |
|
|
|
40 |
|
Contraceptives, Oral, Hormonal |
|
Phase 4 |
|
|
|
41 |
|
Hydrocortisone 17-butyrate 21-propionate |
|
Phase 4 |
|
|
|
42 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
43 |
|
diuretics |
|
Phase 4 |
|
|
|
44 |
|
Mineralocorticoids |
|
Phase 4 |
|
|
|
45 |
|
Mineralocorticoid Receptor Antagonists |
|
Phase 4 |
|
|
|
46 |
|
Neurosteroids |
|
Phase 4 |
|
|
|
47 |
|
Androgens |
|
Phase 4 |
|
|
|
48 |
|
Androgen Antagonists |
|
Phase 4 |
|
|
|
49 |
|
Dacuronium |
|
Phase 4 |
|
|
|
50 |
|
Serotonin Receptor Agonists |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 83)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives. |
Unknown status |
NCT01251263 |
Phase 4 |
Estradiol or Placebo |
2 |
A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine When Used for the Treatment of Premenstrual Dysphoria |
Completed |
NCT00516113 |
Phase 4 |
paroxetine |
3 |
The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder |
Completed |
NCT00678574 |
Phase 4 |
fluoxetine |
4 |
Androgen Hormones in PMDD |
Completed |
NCT00611923 |
Phase 4 |
Flutamide;Placebo |
5 |
Short-Term Versus Long-Term Treatment for Severe PMS |
Completed |
NCT00318773 |
Phase 4 |
sertraline |
6 |
A Comparative Efficacy of Low-dose Combine Oral Contraceptives Containing Desogestrel 150 mg and Drospirenone 3 mg on Premenstrual Symptoms |
Completed |
NCT01482338 |
Phase 4 |
EE 20 microgram with desogestrel 150 mg;EE 20 microgram with drospirenone 3 mg |
7 |
Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment)Of Menstrual Migraine |
Completed |
NCT00904098 |
Phase 4 |
Frovatriptan;Usual Care |
8 |
Evaluation of CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Saliva of Menstrual Migraine Patients Before and After Treatment With Treximet™ |
Completed |
NCT01329562 |
Phase 4 |
Treximet;Placebo |
9 |
An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine |
Completed |
NCT01578941 |
Phase 4 |
|
10 |
Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study |
Terminated |
NCT00523705 |
Phase 4 |
escitalopram |
11 |
EnBrace HR for Premenstrual Syndrome (PMS) With Prominent Mood Symptoms (or Menstrual Related Mood Disorders, MRMD) |
Withdrawn |
NCT04123483 |
Phase 4 |
EnBrace HR Softgel |
12 |
Does Adding Combined Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? A Double Blind Placebo Controlled Study. |
Unknown status |
NCT02562053 |
Phase 3 |
Fluoxetine;Combined oral contraceptives;Placebo 1;Placebo 2 |
13 |
The Synergistic Use of Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in the Management of Severe Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial |
Unknown status |
NCT02488538 |
Phase 3 |
Combined oral contraceptives;Fluoxetine;Combined oral contraceptives placebo;Fluoxetine placebo |
14 |
Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial |
Unknown status |
NCT02427334 |
Phase 3 |
Dienogest;Fluoxetine;Placebo |
15 |
Is Homeopathic Treatment a Placebo Treatment? - Homeopathic Treatment of Premenstrual Syndrome- A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial |
Unknown status |
NCT02402049 |
Phase 3 |
Natrum muriaticum 30C;Lachesis 30C;Sepia 30C;Nux vomica 30C;Pulsatilla 30C;Folliculinum 30C;Placebo Natrum muriaticum;Placebo Lachesis;Placebo Sepia;Placebo Nux vomica;Placebo pulsatilla;Placebo Folliculinum |
16 |
Phase 3 Study Efficacy and Tolerance: The Use of 2 Phytomedicines in Association GAMALINE® 900mg + HIPERICIN® 300mg for the Treatment of Pre-Menstrual Syndrome (PMS) and Vasomotor Symptoms |
Unknown status |
NCT01365676 |
Phase 3 |
GAMALINE® + HIPERICIN®;GAMALINE® |
17 |
Calcium Supplements Versus Oral Contraceptive Pills Containing Drospirenone in Treating Mild to Moderate Premenstrual Syndrome: A Double Blind Randomized Placebo Controlled Trial |
Completed |
NCT02089620 |
Phase 3 |
Yasmin;Placebo 1;Placebo 2 |
18 |
Double-blind Comparison of VAC BNO 1095 Film Coated Tablets With Placebo to Identify Dose Dependent Effects in Patients Suffering From Cyclic Mastodynia and Premenstrual Syndrome |
Completed |
NCT01309113 |
Phase 3 |
VAC BNO 1095 film coated tablets |
19 |
The Impact of Sérélys PMS, a Herbal Remedy Based on Pollen Extraction and Saffron, on Symptoms of PMS: A Randomized, Double-blinded, Placebo Controlled Study |
Completed |
NCT03298607 |
Phase 3 |
|
20 |
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Levonorgestrel 90 Mcg and Ethinyl Estradiol 20 Mcg in a Continuous Daily Regimen on Menstrual Cycle-Related Symptoms |
Completed |
NCT00161681 |
Phase 3 |
Levonorgestrel/Ethinyl Estradiol |
21 |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder |
Completed |
NCT00128934 |
Phase 3 |
levonorgestrel/ethinyl estradiol |
22 |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder |
Completed |
NCT00195559 |
Phase 3 |
Levonorgestrel/Ethinyl Estradiol |
23 |
Prospective, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Randomized Clinical Trial to Proof Efficacy and Safety of 20 mg (2 Tablets of 10 mg) VAC BNO 1095 FCT in Patients Suffering From Cyclic Mastodynia and PMS |
Terminated |
NCT01870687 |
Phase 3 |
20mg VAC BNO 1095 FCT;Placebo |
24 |
Prospective, Controlled, Single-blinded, Longitudinal, Two-arms, Clinical Study Evaluation of Efficacy/Safety of EVE-PMS Skin-Test Panel -Detecting Sensitivity to Sex Hormones in Women With Premenstrual Syndrome |
Unknown status |
NCT00866437 |
Phase 2 |
Skin test panel |
25 |
A Phase II Randomized, Two-arms, Single-blind, Cross Controlled Study for Evaluation the Safety and Efficacy of Diagnosis and Treatment of Premenstrual Syndrome by Detecting Skin Reactions Followed by Desensitization to Sex Hormones |
Unknown status |
NCT00873262 |
Phase 2 |
Skin test panel and desensitization kit;Skin test panel and solvent |
26 |
a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS) |
Completed |
NCT00672607 |
Phase 2 |
extracts of Vitex agnus castus tablets;Placebo |
27 |
The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome |
Completed |
NCT02481973 |
Phase 2 |
|
28 |
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder |
Completed |
NCT00048854 |
Phase 1, Phase 2 |
Sertraline |
29 |
An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome in Indian Females |
Completed |
NCT02467088 |
Phase 2 |
|
30 |
Auriculotherapy in the Cares to the Premenstrual Syndrome: Randomized Clinical Trial |
Completed |
NCT01782040 |
Phase 2 |
|
31 |
An Exploratory Phase II, Randomised, Double-blind, Placebo-controlled, Parallel-group Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine |
Completed |
NCT04102995 |
Phase 2 |
Sepranolone injection low dose;Sepranolone injection high dose;Placebo injection |
32 |
The Treatment of Menstrually-Related Mood Disorders With Extended Versus Interrupted Oral Contraceptives |
Terminated |
NCT00089414 |
Phase 2 |
Ethinyl Estradiol/Drospirenone;Placebo;CDB 2914 |
33 |
The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women With Menstrual-Related Mood Disorders and Controls |
Completed |
NCT00082043 |
Phase 1 |
Dutasteride;Placebo oral capsule |
34 |
The Treatment of Menstrually-Related Mood Disorders With the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron) |
Completed |
NCT00001259 |
Phase 1 |
Leuprolide;Estradiol Patches;Progesterone |
35 |
Evaluation of the Effect of Different Acupuncture Dose on Premenstrual Syndrome and the Relationship Between Premenstrual Syndrome and TCM Syndrome Complex |
Unknown status |
NCT04296422 |
|
NSAIDs or oral contraceptives treatment |
36 |
The Study of Efficacy and Effect of Different Dose Acupuncture on Autonomic Nervous Activity and Quality of Life in Women With Dysmenorrhea |
Unknown status |
NCT03881319 |
|
Conventional gynecologic treatment |
37 |
The Symptom Experience of Women With Perimenstrual Syndrome;Women's Health Related Quality of Life. |
Unknown status |
NCT00174161 |
|
|
38 |
Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine |
Unknown status |
NCT02592681 |
|
|
39 |
Detecting Auricular Points Among Patients With Menstrual Migraine by A Novel Auricular Point Detector (APD): A Pilot Diagnostic Accuracy Study |
Unknown status |
NCT03702114 |
|
|
40 |
Evaluating Treatment With Homeopathy, Acupuncture, and Anthroposophic Medicine in Improving the Quality of Life for Women Treated at the Public Unified Healthcare System |
Unknown status |
NCT02504515 |
|
|
41 |
Foot Reflexology Combined With Dietary Modification on Premenstrual Syndrome |
Completed |
NCT04348201 |
|
|
42 |
Development and Evaluation of an Internet-based Cognitive Behaviour Therapy for Women With Premenstrual Syndrome (PMS) |
Completed |
NCT01961479 |
|
|
43 |
Effects of Aerobic Exercise on the Symptoms of Premenstrual Syndrome and Dysmenorrhoea and Blood Flow of Genital Tract: A Prospective Interventional Study |
Completed |
NCT04618172 |
|
|
44 |
Effect of Aeropbic Exercise as Swimming on Premenstrual Syndrome |
Completed |
NCT03264612 |
|
|
45 |
Study to Evaluate the Efficacy of Your Super's Moon Balance and Its Impact on Premenstrual Syndrome and Menstrual Symptoms |
Completed |
NCT05237661 |
|
|
46 |
Effect of Sufficient Dietary Calcium Intake in Women With Premenstrual Syndrome |
Completed |
NCT02809066 |
|
|
47 |
Effect of Whole-body Vibration Versus Aerobic Exercise on the Inflammatory Status and Hormonal Parameters in Females With Premenstrual Syndrome |
Completed |
NCT04855981 |
|
|
48 |
Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome: an Observational Study |
Completed |
NCT04901598 |
|
|
49 |
Effect of Aerobic Exercise Training on Premenstrual Syndrome Symptoms and Health Related Quality of Life Among Working Women |
Completed |
NCT05349344 |
|
|
50 |
The Effect of Nutrition Education on Premenstrual Syndrome: Randomized Controlled Study |
Completed |
NCT05144568 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Ibuprofen
Mefenamic Acid
|
pamabrom
solufenum
|
|